Does Rallies show Form 4 insider transactions for LFMD?

Yes. Rallies tracks LFMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is LFMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LFMD. It does not provide personalized investment advice.

LFMD (LifeMD, Inc. Common Stock) Stock Analysis - Insider Trades

LifeMD, Inc. Common Stock (LFMD) is a publicly traded Healthcare sector company. As of May 21, 2026, LFMD trades at $4.36 with a market cap of $205.06M and a P/E ratio of 17.26. LFMD moved -0.93% today. Year to date, LFMD is +8.95%; over the trailing twelve months it is -59.96%. Its 52-week range spans $2.56 to $15.84. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces LFMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading LFMD stock inside the company?

Recent LFMD insider activity includes FRIEDEMAN JESSICA sold 15.00K, Alvarez Nicholas P sold 75.00K, Schreiber Justin sold 25.00K, Schreiber Justin sold 25.00K, and Benathen Marc David sold 50.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

LFMD Key Metrics

Key financial metrics for LFMD
Metric	Value
Price	$4.36
Market Cap	$205.06M
P/E Ratio	17.26
EPS	$0.25
Dividend Yield	0.00%
52-Week High	$15.84
52-Week Low	$2.56
Volume	1
Avg Volume	0
Revenue (TTM)	$194.06M
Net Income	$15.62M
Gross Margin	85.72%

Recent LFMD Insider Trades

FRIEDEMAN JESSICA sold 15.00K (~$54.16K) on Dec 9, 2025.
Alvarez Nicholas P sold 75.00K (~$443.76K) on Sep 10, 2025.
Schreiber Justin sold 25.00K (~$249.69K) on Jul 1, 2025.
Schreiber Justin sold 25.00K (~$334.46K) on Jul 1, 2025.
Benathen Marc David sold 50.00K (~$700.50K) on Jun 17, 2025.

Latest LFMD News

LifeMD Q1 Revenue Hits $50.2M with 88% Margin and 42,000 Subscriber Net Adds — May 6, 2026
LifeMD Adds Foundayo Oral GLP-1 Pill at $149/Month for Weight Management — Apr 10, 2026
LifeMD Joins Wegovy Subscription Program, Enrolling Patients at $249 Monthly — Mar 31, 2026
LifeMD Grants CFO 675,000 RSUs and Expands Executive Leadership Team — Mar 16, 2026
LifeMD Divests WorkSimpli, Eyes 42% Upside to $10 on Telehealth Push — Mar 12, 2026

LFMD Analyst Consensus

5 analysts cover LFMD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.00.

Common questions about LFMD

Who is trading LFMD stock inside the company?: Recent LFMD insider activity includes FRIEDEMAN JESSICA sold 15.00K, Alvarez Nicholas P sold 75.00K, Schreiber Justin sold 25.00K, Schreiber Justin sold 25.00K, and Benathen Marc David sold 50.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LFMD?: Yes. Rallies tracks LFMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LFMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LFMD. It does not provide personalized investment advice.